Søgeresultater - Subha Vogeti

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages

    Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages af Bryan D. Smith, Michael D. Kaufman, Scott Wise, Yu Mi Ahn, Timothy M. Caldwell, Cynthia B. Leary, Wei-Ping Lu, Gege Tan, Lakshminarayana Vogeti, Subha Vogeti, Breelyn A. Wilky, Lara E. Davis, Maitreyi G. Sharma, Rodrigo Ruiz‐Soto, Daniel L. Flynn

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

    Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2 af Bryan D. Smith, Michael D. Kaufman, Cynthia B. Leary, Benjamin A. Turner, Scott Wise, Yu Mi Ahn, R J Booth, Timothy M. Caldwell, Carol L. Ensinger, Molly M. Hood, Wei-Ping Lu, Tristan W. Patt, William C. Patt, Thomas J. Rutkoski, T. Samarakoon, Hanumaiah Telikepalli, Lakshminarayana Vogeti, Subha Vogeti, Karen Yates, Lawrence Chun, Lance Stewart, Michael Clare, Daniel L. Flynn

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers

    Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers af Sheng-Bin Peng, James R. Henry, Michael D. Kaufman, Wei-Ping Lu, Bryan D. Smith, Subha Vogeti, Thomas J. Rutkoski, Scott Wise, Lawrence Chun, Youyan Zhang, Robert D. Van Horn, Tinggui Yin, Xiaoyi Zhang, Vipin Yadav, Shih-Hsun Chen, Xueqian Gong, Xiwen Ma, Yue Webster, Sean G. Buchanan, Igor Mochalkin, Lysiane Huber, Lisa Kays, Gregory P. Donoho, Jennie Walgren, Denis McCann, Phenil J. Patel, Ilaria Conti, Gregory D. Plowman, James J. Starling, Daniel L. Flynn

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

    Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants af Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B. Leary, Scott Wise, Thomas J. Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L. Bulfer, Timothy M. Caldwell, Lawrence Chun, Carol L. Ensinger, Molly M. Hood, Arin McKinley, William C. Patt, Rodrigo Ruiz‐Soto, Ying Su, Hanumaiah Telikepalli, Ajia Town, Benjamin A. Turner, Lakshminarayana Vogeti, Subha Vogeti, Karen Yates, Filip Janků, Albiruni Ryan Abdul Razak, Oliver Rosen, Michael C. Heinrich, Daniel L. Flynn

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-<i>d</i>]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against <i>BRAF</i> or <i>RAS</i> Mutant Tumor Cells

    Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-<i>d</i>]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Pa... af James R. Henry, Michael D. Kaufman, Sheng-Bin Peng, Yu Mi Ahn, Timothy M. Caldwell, Lakshminarayana Vogeti, Hanumaiah Telikepalli, Wei-Ping Lu, Molly M. Hood, Thomas J. Rutkoski, Bryan D. Smith, Subha Vogeti, David F. Miller, Scott Wise, Lawrence Chun, Xiaoyi Zhang, Youyan Zhang, Lisa Kays, Philip A. Hipskind, A.D. Wrobleski, Karen L. Lobb, Julia M. Clay, Jeffrey Cohen, Jennie Walgren, Denis McCann, Phenil J. Patel, David K. Clawson, Sherry Guo, Danalyn Manglicmot, C. Groshong, Cheyenne Logan, James J. Starling, Daniel L. Flynn

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: